Who owns the X10D trademark?

The X10D trademark is owned by Xvivo Perfusion Aktiebolag.

What is the serial number for X10D?

The USPTO serial number for X10D is 79273309.

What is the registration number for X10D?

X10D is registered under USPTO registration number 6375019.

X10

USPTO Trademark Record

REGISTERED

X10D

Q: What class is the X10D trademark registered in?

The X10D trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79273309·Reg 6375019·Filed Jul 04, 2019

Owner Xvivo Perfusion Aktiebolag

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

X10D (Serial No. 79273309), Registration No. 6375019, is a registered US trademark filed on Jul 04, 2019 by Xvivo Perfusion Aktiebolag. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Renewal window: June 08, 2027253 days remaining

Mark Intelligence

X10D (Reg. #6375019) is a registered US trademark that has been protecting its owner, Xvivo Perfusion Aktiebolag, since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 6 opposition proceedings during prosecution.

FILED

Jul 04, 2019

SERIAL

79273309

REG#

6375019

REGISTERED

Jun 08, 2021

Owner

Applicant

Xvivo Perfusion Aktiebolag

Entity

AB (Swedish)

Address

Box 53015, SE-400 14 Göteborg

Country

Attorney

NameMichael J. Hynak

Law firm

Michael J. Hynak Hynak & Associates, PC

Docket

332.284

Address

812 South Courthouse Rd., Arlington, VA 22204, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 04, 2019

Serial Number79273309

Registration No.6375019

Registration DateJun 08, 2021

Status DateJun 08, 2021

Published for OppositionMar 23, 2021

Mark TypeStandard characters

Attorney Docket332.284

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 6× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jun 08, 2026

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

NEW REPRESENTATIVE AT IB RECEIVED

Nov 25, 2023

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Oct 24, 2021

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Sep 27, 2021

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Sep 27, 2021

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Sep 08, 2021

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jun 08, 2021

REGISTERED-PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

May 23, 2021

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

May 05, 2021

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

May 05, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

PUBLISHED FOR OPPOSITION

Mar 23, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 23, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Mar 21, 2021

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 03, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Mar 03, 2021

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 03, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

EXAMINERS AMENDMENT -WRITTEN

Feb 16, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 16, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 16, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 16, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 16, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW REPRESENTATIVE AT IB RECEIVED

Jan 22, 2021

NEW REPRESENTATIVE AT IB RECEIVED

FINAL REFUSAL WRITTEN

Aug 03, 2020

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Aug 03, 2020

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Aug 03, 2020

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 03, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 03, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 03, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jan 24, 2020

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jan 07, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 07, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

APPLICATION FILING RECEIPT MAILED

Dec 10, 2019

APPLICATION FILING RECEIPT MAILED

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 10, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Dec 09, 2019

NON-FINAL ACTION WRITTEN

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 06, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Dec 06, 2019

ASSIGNED TO EXAMINER

SN ASSIGNED FOR SECT 66A APPL FROM IB

Dec 05, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

X10D

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Xvivo Perfusion Aktiebolag

Other Marks by Michael J. Hynak

Resources

Company